Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 October 2027, 10:00 (CEST) to 12 October 2027, 16:00 (CEST)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 16 November 2027, 09:30 (CET) to 16 November 2027, 13:30 (CET)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 7 December 2027, 09:30 (CET) to 7 December 2027, 13:30 (CET)

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Revision: 3, Status: Authorised

Medicine Shortages SPOC Working Party meetings

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of authorisation: 21/04/2013, Revision: 15, Status: Authorised

Withdrawn application: Ibrance, 15/10/2026

Human medicines European public assessment report (EPAR): Lamivudine Teva Pharma B.V., lamivudine, Date of authorisation: 10/12/2009, Revision: 20, Status: Authorised